SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044537
Filing Date
2024-11-12
Accepted
2024-11-12 08:05:33
Documents
53
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1084810
2 ex31-1.htm EX-31.1 20202
3 ex31-2.htm EX-31.2 20405
4 ex32-1.htm EX-32.1 8269
5 ex32-2.htm EX-32.2 8209
  Complete submission text file 0001493152-24-044537.txt   3696407

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE indp-20240930.xsd EX-101.SCH 23168
7 XBRL CALCULATION FILE indp-20240930_cal.xml EX-101.CAL 38765
8 XBRL DEFINITION FILE indp-20240930_def.xml EX-101.DEF 59712
9 XBRL LABEL FILE indp-20240930_lab.xml EX-101.LAB 257369
10 XBRL PRESENTATION FILE indp-20240930_pre.xml EX-101.PRE 196774
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 361467
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40652 | Film No.: 241443552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)